Who is sponsoring NCT03915977?

NCT03915977 is sponsored by Holbaek Sygehus.

What drugs are being tested in NCT03915977?

Interventions in NCT03915977: Post ICU recovery program.

What condition does NCT03915977 study?

NCT03915977 studies Intensive Care Unit Syndrome.

Is NCT03915977 still recruiting?

NCT03915977 is currently completed. Last updated 9 August 2019.

Last reviewed 2019-08-09 · How we verify

NCT03915977

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patterns of PTSD in Adult Patients After Intensive Care

Completed Last updated 9 August 2019

What this trial tests

trial testing Post ICU recovery program in Intensive Care Unit Syndrome in 386 participants. Completed in 1 December 2015.

Timeline

2 December 2012

Primary endpoint
1 December 2015

1 December 2015

Quick facts

Lead sponsor	Holbaek Sygehus
Status	Completed
Study type	OBSERVATIONAL
Enrollment	386
Start date	2 December 2012
Primary completion	1 December 2015
Estimated completion	1 December 2015
Sites	1 location across Denmark

Drugs / interventions tested

Post ICU recovery program

Conditions studied

Intensive Care Unit Syndrome — all drugs for Intensive Care Unit Syndrome →

Sponsor

Holbaek Sygehus — full company profile →

Who can join

18 and older, any sex, with Intensive Care Unit Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to describe adult patients' patterns of Post-traumatic stress disorder (PTSD) at discharge, 3, and 12 months after intensive care.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Intensive Care Unit Syndrome

Currently open trials in the same condition.

NCT06427265 — Machine Learning-based Longitudinal Study of Post-ICU Syndrome Development Trajectory in Critically Ill Patients and Con · recruiting
NCT03753412 — Recovery From ICUAW Following Severe Respiratory and Cardiac Failure · recruiting

Other Holbaek Sygehus trials

Trials by the same sponsor.

NCT06022120 — Health Literacy Among Youth · NA · completed
NCT05250752 — Reduction of Peritoneal Glucose Uptake With Use of SGLT2 in Humans Undergoing Peritoneal Dialysis Treatment · Phase 2 · unknown
NCT05101473 — Exercise Therapy for People With a Diabetic Foot Ulcer - a Feasibility Study · NA · completed
NCT05866978 — An Integrated Approach to Health, Wellbeing, and Productivity at Work · NA · unknown
NCT04542785 — Lenient Rate Control Versus Strict Rate Control for Atrial Fibrillation. The Danish Atrial Fibrillation Randomised Clini · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03915977 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Holbaek Sygehus
Last refreshed: 9 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03915977.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing